CTRI/2016/02/006681
Active, not recruiting
Phase 3
Assesment of Neuropsychopharmacological action of Polyherbal formulation in association with regulation of Biomarkers and sleep pattern in Mild to Moderate Depressed patients. - Sleep, Melatonin and Depression
Interdisciplinary Institute of Indian System of Medicine University Building Fourth Floor0 sites60 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Depressive symptoms with cognitive impairment, Sleep Disturbances
- Sponsor
- Interdisciplinary Institute of Indian System of Medicine University Building Fourth Floor
- Enrollment
- 60
- Status
- Active, not recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with age between 30 \- 65 years (Both genders)
- •2\. Patient health questionnaire (PHQ\-9\) scores 5\-14
- •3\. Hamilton depression rating scale score 19\-22\.
- •4\.Patient must meet the DSM\-V Criteria for Depression.
- •Patients willing to give informed consent.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Sub(acute) Profiling of 2C-B Versus PsilocybiNL-OMON28125Maastricht University18
Completed
Not Applicable
Sub(acute) Neuropsychopharmacological Profiling of 2C-B vs Psilocybindrug effects, drug metabolitesNot applicableNL-OMON50024niversiteit Maastricht24
Completed
Not Applicable
Effectiveness of Neuropsychological interventions for improving academic performancemathematics learning disabilities.Developmental disorder of scholastic skills, unspecifiedIRCT138905134510N1researcher30
Completed
Not Applicable
The investigation of the antipsychotic effects of adding d-penicillamine to risperidone on schizophrenia.schizophrenia.?????????IRCT20131007014928N6Mazandaran University of Medical Science.32
Recruiting
Not Applicable
the study of "the effect of the psychotropic (hypnotic) drugs, antipsychotic drugs, and/or antidepressant drugs on clinical symptoms, sleep quality, cognitive function, daily activity, health related quality of life, and survival in patients with chronic hypercapnic respiratory failure who have received long-term oxygen therapy and/or nocturnal noninvasive positive pressure ventilation for a long time."patients with chronic hypercapnic respiratory failure receiving a long-term oxygen therapy and/or noninvasive positive pressure ventilation (NPPV)JPRN-UMIN000010608Department of Respiratory Medicine, Natonal Hospital Orgnization MInami-Kyoto Hospital600